hands-on experience in accounting and finance, with responsibilities across both the Financial Planning & Analysis... in Accounting or Finance. Attention to detail, proficient in MS Office applications, especially Excel. Ability to prioritize...
[What the role is] As an Associate Lecturer, your key contributions will be in teaching and facilitating learning for students in ITE. You will play a role in recognising and nurturing your students' potential and their learning needs, and...
accounting of financial transactions in the financial system. - Prepare regulatory reports, budgets, statistics, and claims.... What we are looking for: Academic training in Accounting or a related field. At least 3 years of experience in accounting operations, preferably...
in Singapore and Australia. This role involves overseeing accounting functions, preparing financial statements, and ensuring... compliance with both Singapore and Australian accounting standards. The ideal candidate will have strong analytical skills, cross...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »